Name: Mechanistic & Discovery Toxicology in the era of AI and NAMs
Start: 2026-06-16T09:00:00+01:00
End: 2026-06-16T18:00:00+01:00
Location: GSK Stevenage

Mechanistic & Discovery Toxicology in the era of AI and NAMs

An interactive meeting on how mechanistic & discovery toxicology integrates in silico, in vitro, and in vivo approaches to de‑risk new drugs
About this Event

Cambridge Alliance on Medicines Safety (CAMS) and The British Toxicology Society (BTS) DiscoTox group are pleased to announce an exciting joint event on June 16th 2026 at GSK in Stevenage, where we explore ‘Mechanistic & Discovery Toxicology in the era of AI and NAMS’.

This free wide-ranging meeting will showcase how mechanistic and discovery toxicology integrates in silico, in vitro, and short‑term in vivo approaches to de‑risk new drugs and new modalities, with speakers from across industry, biotech, and academia.

Please use this page to register for this event.

We will showcase a number of 5 minute short talks selected from submitted abstracts, so please indicate whether you would like to be considered for this during registration.

Abstract submission for Poster Presentations are welcomed. Details on how to submit Abstracts are detailed within this form. The deadline for all Abstract submissions is Wednesday 15th April 2026.

Please see below for details and to register interest in this event including short talk and poster options.

Full agenda details will follow.

Location of event:

Lecture Theatre, GSK, Stevenage, SG1 2NY

Parking:

We encourage public transport to the venue where possible.

More information will be provided to all nearer the time.

Agenda:

We have some brilliant speakers lined up for this event. Please visit the Cambridge Academy of Therapeutic Sciences website for more information.

------------------------------------------------------------------------------------------------------

If you choose to submit an abstract for a poster presentation, you must agree to the following:

A. The abstract is scientifically sound and ethically approved.

B. The abstract is not an advertisement, nor contains anything obscene, defamatory, libellous, unlawful or in any way actionable. Any such abstracts will be rejected.

C. The abstract Title will be included unedited in the Congress programme/app. It is the authors’ responsibility to check the abstract for spelling mistakes/other errors prior to submission. These will not be edited during the abstract review process.

D. All authors have seen and approved the abstract as submitted.

E. The work has not previously been accepted for publication.

F. If your abstract is accepted, you must agree to register for CAMS-DiscoTOX 2026 and present your research as a poster or oral presentation.